Hellman & Friedman's PPD shows PE growth in action

Pharmaceutical Product Development goes public eight years after H&F and Carlyle completed its buyout.

11 February 2020•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.